CardioComm Solutions, Inc., together with its subsidiary, CardioView Inc., develops software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. Its technology is used in a range of products for the recording, transmission, viewing, analyzing, reporting, and storage of ECGs for arrhythmia screening, diagnosis, and management of cardiac patients. The company's software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 12 Lead, a Web enabled ECG device that is EMR compatible; and GEMS Lite for Windows, an electronic ECG receiving system. It also offers software modules, such as GEMS WIN Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 and EMR Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; and GlobalCardio EMR integration that enables bidirectional movement of data, including patient information, reports, and links. In addition, the company provides hardware products comprising HeartCheck PEN and HeartCheck, a handheld ECG monitor; and Sirona telephonic and wireless event recorders. Further, it offers ASP services, including C4 ECG management services; and HeartCheck SMART Monitoring, an ECG reading service, as well as provides other products comprising GlobalCardio 3 Lead; ECG Viewer SDK; QRS Diagnostic; and QRS 12 Lead Universal products. The company sells its products to medical professionals, patients, healthcare professionals, ECG commercial reading services, physicians, hospitals through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.
Industry, Sector and Symbol
Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CIKN/A
Phone+1-416-9779425
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$990,725.00
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
CardioComm Solutions (CVE:EKG) Frequently Asked Questions
What is CardioComm Solutions' stock symbol?
CardioComm Solutions trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EKG."
Has CardioComm Solutions been receiving favorable news coverage?
News headlines about EKG stock have been trending negative on Wednesday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. CardioComm Solutions earned a media sentiment score of -2.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for CardioComm Solutions.
Who are some of CardioComm Solutions' key competitors?
Some companies that are related to CardioComm Solutions include 1ST Group (1ST), Oneview Healthcare (ONE), ICSGlobal (ICS), Diagnos (ADK), Jayex Healthcare (JHL), Novita Healthcare (NHL), Global Health (GLH), 10x Genomics (TXG), eWELLNESS HEALTHCARE (EWLL), NMC Health (PMCUF), US-China Biomedical Technology (UCBB) and ZoomMed (ZMD).
Who are CardioComm Solutions' key executives?
CardioComm Solutions' management team includes the folowing people:
- Mr. Etienne Grima, CEO, Corp. Sec. & Director
- Mr. Simi Grosman, Consultant & Director
- Ms. Anne Burpee, Chief Financial Officer
How do I buy shares of CardioComm Solutions?
Shares of EKG and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is CardioComm Solutions' stock price today?
One share of EKG stock can currently be purchased for approximately C$0.04.
How big of a company is CardioComm Solutions?
What is CardioComm Solutions' official website?
How can I contact CardioComm Solutions?
CardioComm Solutions' mailing address is 259 Yorkland Rd 2nd Floor, NORTH YORK, ON M2J 0B5, Canada. The company can be reached via phone at +1-416-9779425.
MarketBeat Community Rating for CardioComm Solutions (CVE EKG)
MarketBeat's community ratings are surveys of what our community members think about CardioComm Solutions and other stocks. Vote "Outperform" if you believe EKG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EKG will underperform the S&P 500 over the long term. You may vote once every thirty days.
